Previous 10 | Next 10 |
SAN DIEGO and SUZHOU and SHANGHAI, China, July 31, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of canc...
Gracell Biotechnologies Inc. (NASDAQ: GRCL) is one of today's top gainers. The company's shares are currently up 24.61% on the day to $4. Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the...
2023-06-30 12:31:22 ET Gainers: Cyteir Therapeutics ( CYT ) +39% . Renalytix ( RNLX ) +39% . Rackspace Technology ( RXT ) +29% . Friedman Industries ( FRD ) +23% . Gracell Biotechnologies ( GRCL ) +23% . CytomX Therapeutics (...
2023-06-20 17:42:47 ET Gainers: 2U ( TWOU ) +7% . Silk Road Medical ( SILK ) +4% . ROC Energy Acquisition ( ROC ) +4% . AXT ( AXTI ) +4% . CVB Financial ( CVBF ) +3% . Losers: LifeStance Health Group ( LFST ) ...
2023-06-20 10:07:39 ET Gainers: DICE Therapeutics ( DICE ) +38% . iCAD ( ICAD ) +17% . Nuwellis ( NUWE ) +14% . Valneva ( VALN ) +14% . Cano Health ( CANO ) +13% . Losers: Surgalign ( SRGA ) -72% . Gracel...
SAN DIEGO and SUZHOU and SHANGHAI, China, June 20, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of canc...
2023-06-13 15:29:56 ET Shares of Gracell Biotechnologies (NASDAQ: GRCL) were up 21.5% Tuesday afternoon. The healthcare stock rose for the second consecutive day, boosted by an analyst's upgrade, as well as by positive trial news. The stock is up more than 156% so far this year....
2023-06-13 08:20:35 ET Auddia ( AUUD ) -37% . Advanced Health Intelligence ( AHI ) -28% . Finch Therapeutics Group ( FNCH ) -22% . Asset Entities ( ASST ) -18% . Jin Medical International Ltd. ( ZJYL ) -16% on releasing new-generatio...
Gracell Biotechnologies Inc. (NASDAQ: GRCL) is one of today's top gainers. The company's shares are currently up 20% on the day to $4.8. Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the ...
2023-06-12 13:17:32 ET Gainers: Asset Entities ( ASST ) +95% . Jin Medical International ( ZJYL ) +68% . Chinook Therapeutics ( KDNY ) +58% . Infobird ( IFBD ) +42% . Micromobility.com ( MCOM ) +39% . Freightos Limited ( CR...
News, Short Squeeze, Breakout and More Instantly...
Gracell Biotechnologies Inc. Company Name:
GRCL Stock Symbol:
NASDAQ Market:
Gracell Biotechnologies Inc. Website:
Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell ...
Gracell Biotechnologies Inc. (NASDAQ: GRCL) is the focus of IBN's latest stock spotlight. The company's shares have moved -0.49% on the day to $10.19. Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of ...